Hospital Partnerships And Demographic Tailwinds Will Expand Home-Based Healthcare

Published
05 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
CA$6.60
55.0% undervalued intrinsic discount
15 Aug
CA$2.97
Loading
1Y
-23.7%
7D
4.6%

Author's Valuation

CA$6.6

55.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on15 Aug 25

Quipt Home Medical’s Future P/E has risen significantly from 15.16x to 20.94x, indicating higher growth expectations relative to earnings, while the analyst price target remains unchanged at CA$6.60. What's in the News Quipt Home Medical received a non-binding buyout proposal from Forager Capital Management at $3.10 per share, a 121% premium above its prior stock price.

Shared on01 May 25
Fair value Decreased 6.25%

Shared on24 Apr 25
Fair value Decreased 0.56%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 3.67%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25